Researchers at the University of Texas at Austin studied a set of antibodies that targeted the spike protein. Their findings are noteworthy because they suggest that the effectiveness of SARS-CoV-2 stems from obtaining mutations that evade the most successful antibodies. Read our summary to look at the key statistics from the study! To learn more about this, check out this article from the NIH.
medgrphx 